UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

Journal of cardiovascular electrophysiology, 2009-03, Vol.20 (3), p.241-248

2009

Volltextzugriff (PDF)

Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: Results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study

Heart rhythm, 2014-06, Vol.11 (6), p.992-1000

2014

Volltextzugriff (PDF)

Quality of life in patients with atrial fibrillation: how to assess it and how to improve it

Europace (London, England), 2014-06, Vol.16 (6), p.787-796

2014

Volltextzugriff (PDF)

Clinical outcomes in patients with systolic heart failure. Are atrial high rate episodes a common marker of disease progression?

International journal of cardiology, 2020-10, Vol.316, p.184-185

2020

Volltextzugriff (PDF)

International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF)

Europace (London, England), 2022-07, Vol.24 (6), p.899-909

2022

Volltextzugriff (PDF)

Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill-in-the-Pocket” Approach

The New England journal of medicine, 2004-12, Vol.351 (23), p.2384-2391

2004

Volltextzugriff (PDF)

Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation

Europace (London, England), 2019-12, Vol.21 (12), p.1764-1775

2019

Volltextzugriff (PDF)

The VALID‐CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real‐world population

Clinical cardiology (Mahwah, N.J.), 2019-10, Vol.42 (10), p.919-924

2019

Volltextzugriff (PDF)

The stricter criteria for Class I CRT indication suggested by the 2016 ESC Guidelines reliably exclude patients with a worse prognosis in comparison with the 2013 ESC indication criteria

International journal of cardiology, 2018-12, Vol.273, p.162-167

2018

Volltextzugriff (PDF)

Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment

Heart (British Cardiac Society), 2010-04, Vol.96 (7), p.546-549

2010

Volltextzugriff (PDF)

Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohort

Journal of cardiovascular medicine (Hagerstown, Md.), 2020-09, Vol.21 (9), p.634

2020

Volltextzugriff (PDF)

‘Pill-in-the-pocket’ treatment for recent-onset atrial fibrillation

Heart (British Cardiac Society), 2010-10, Vol.96 (19), p.1605-1606

2010

Volltextzugriff (PDF)

Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial

Trials, 2011-02, Vol.12 (1), p.44-44, Article 44

2011

Volltextzugriff (PDF)

Abstract 12731: Cardiac Resynchronization Therapy Improves Diastolic Function and Reduces New Onset Atrial Fibrillation in Patients With Prolonged Atrioventricular Interval: The Pilot Randomized Controlled Real-crt Study

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A12731-A12731

2019

Volltextzugriff (PDF)

Role of verapamil in atrial fibrillation: effect on trigger or on substrate? Data from the VeRAF study

Journal of the American College of Cardiology, 2002-03, Vol.39, p.82-83

2002

Volltextzugriff (PDF)

Verapamil around electrical cardioversion of persistent atrial fibrillation: results from the VeRAF study

Journal of the American College of Cardiology, 2002-03, Vol.39, p.91-91

2002

Volltextzugriff (PDF)

Modulation of ventricular rate in permanent atrial fibrillation: Randomized, crossover study of the effects of slow‐release formulations of gallopamil, diltiazem, or verapamil

Clinical cardiology (Mahwah, N.J.), 1998-11, Vol.21 (11), p.837-840

1998

Volltextzugriff (PDF)

Cardioversion of Atrial Fibrillation: Recent Developments

Cardiac electrophysiology review, 2001-08, Vol.5 (2-3), p.189

2001

Volltextzugriff (PDF)

Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects

Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2005-06, Vol.6 (6), p.335

2005

Volltextzugriff (PDF)

CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how?

European journal of heart failure, 2018-06, Vol.20 (6), p.1039-1051

2018

Volltextzugriff (PDF)

Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers

Journal of the American College of Cardiology, 2005-11, Vol.46 (10), p.1913-1920

2005

Volltextzugriff (PDF)

Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies

Journal of the American College of Cardiology, 2024-05, Vol.83 (19), p.1841-1851

2024

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: Results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study

Quality of life in patients with atrial fibrillation: how to assess it and how to improve it

Clinical outcomes in patients with systolic heart failure. Are atrial high rate episodes a common marker of disease progression?

International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF)

Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill-in-the-Pocket” Approach

Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation

Closed loop stimulation reduces the incidence of atrial high-rate episodes compared with conventional rate-adaptive pacing in patients with sinus node dysfunctions

The VALID‐CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real‐world population

The stricter criteria for Class I CRT indication suggested by the 2016 ESC Guidelines reliably exclude patients with a worse prognosis in comparison with the 2013 ESC indication criteria

Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment

Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohort

‘Pill-in-the-pocket’ treatment for recent-onset atrial fibrillation

Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial

Abstract 12731: Cardiac Resynchronization Therapy Improves Diastolic Function and Reduces New Onset Atrial Fibrillation in Patients With Prolonged Atrioventricular Interval: The Pilot Randomized Controlled Real-crt Study

Role of verapamil in atrial fibrillation: effect on trigger or on substrate? Data from the VeRAF study

Verapamil around electrical cardioversion of persistent atrial fibrillation: results from the VeRAF study

Modulation of ventricular rate in permanent atrial fibrillation: Randomized, crossover study of the effects of slow‐release formulations of gallopamil, diltiazem, or verapamil

Cardioversion of Atrial Fibrillation: Recent Developments

Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects

CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how?

Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers

Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies

Suchergebnisse filtern